AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5B
Insilico Medicine, the Hong Kong-listed AI drug discovery company, has signed a partnership with Korea’s SK Biopharmaceuticals to help develop ...
Thursday, August 6, 2026
Tag: Biopharmaceuticals
Insilico partners with SK Biopharmaceuticals in $2.5B AI drug pact (ISLMF:OTCMKTS)
Insilico Medicine (ISLMF) and SK Biopharmaceuticals have partnered to develop AI-driven drug candidates for central nervous system neuroimmune disorders. The deal ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.